Treatment with an anthracycline

Cardiomyopathy - Treatment with an anthracycline Factor

Last reviewed for CCPS 18 July 2007.

Preliminary questions [20721]

20746 there is some evidence that treatment with anthracyclines may be a factor in the development or worsening of the condition under consideration.

20762 the veteran has been treated with an anthracycline at some time.

20772 — the veteran was treated with an anthracycline for an illness or injury which is identifiable. [Default true]

20763 — the veteran has established the causal connection between treatment with an anthracycline and VEA service for cardiomyopathy.

20766 the veteran was treated with an anthracycline for the identified illness or injury before the clinical onset of the condition under consideration.

20764 — the veteran has established the causal connection between treatment with an anthracycline and VEA service for the clinical onset of cardiomyopathy.

20768 — the veteran has established the causal connection between treatment with an anthracycline and operational service for the clinical onset of cardiomyopathy.

or

20769 — the veteran has established the causal connection between treatment with an anthracycline and eligible service for the clinical onset of cardiomyopathy.

or

7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

20767

the veteran was treated with an anthracycline for the identified illness or injury before the clinical worsening of the condition under consideration.

20765 — the veteran has established the causal connection between treatment with an anthracycline and VEA service for the clinical worsening of cardiomyopathy.

20770 — the veteran has established the causal connection between treatment with an anthracycline and operational service for the clinical worsening of cardiomyopathy.

or

20771 — the veteran has established the causal connection between treatment with an anthracycline and eligible service for the clinical worsening of cardiomyopathy.

Clinical onset and operational service [20768]

20773 — the identified illness or injury for which the treatment with an anthracycline was given is causally related to operational service.

Clinical onset and eligible service [20769]

20774 — the identified illness or injury for which the treatment with an anthracycline was given is causally related to eligible service.

Clinical worsening and operational service [20770]

20773 — the identified illness or injury for which the treatment with an anthracycline was given is causally related to operational service.

20775

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, that was treated with an anthracycline, is causally related.

Clinical worsening and eligible service [20771]

20774 — the identified illness or injury for which the treatment with an anthracycline was given is causally related to eligible service.

20776

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, that was treated with an anthracycline, is causally related.